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SUMMARY
1. The whole-cell variation of the patch clamp technique was used to study the
effect of calcitonin gene-related peptide (CGRP) on voltage-gated calcium currents
in acutely dissociated rat nodose ganglion neurones and to determine if its effects
were mediated via a guanine nucleotide binding (G) protein.
2. Both low- and high-threshold calcium current components were present in
nodose ganglion neurones. CGRP had no effect on the isolated low-threshold current
component. However, CGRP (1-1000 nM, ED50 = 50 nM) caused a concentration-
dependent increase in high-threshold calcium currents. CGRP (1 /tM) increased the
peak of these calcium currents 21 +4% over controls.
3. CGRP enhanced a transient high-threshold calcium current evoked from a
holding potential of -80 mV but did not affect the slowly inactivating high-
threshold current evoked from -40 mV. Multiple high-threshold calcium currents
have been reported in sensory neurones. We cannot state unequivocally which high-
threshold calcium current component was enhanced by CGRP. However, based on
the observation that CGRP increased a transient but not the slowly inactivating
high-threshold calcium current, we believe the peptide enhanced primarily the N-
type calcium current component.
4. CGRP increased the maximal peak current and caused a modest negative shift
of < 10 mV in the peak of the current-voltage (I-V) relation in three of six neurones.
In the remaining three neurones the peptide increased the maximal peak current
without a detectable shift in the peak of the I-V relation.
5. To determine if the CGRP-induced enhancement in calcium current was
associated with an increase in calcium conductance, we studied the effect of the
peptide on the instantaneous current-voltage (I-V) relation when currents were
evoked at a clamp potential (VJ) of + 30 mV, positive to the observed maximal
current (VT = 0 to +10 mV). CGRP increased the maximal conductance 23 + 4 %.
6. The enhancement of calcium current by CGRP was not due to a shift in the
voltage dependency of steady-state inactivation of the calcium channels. The
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stimulatory effect of CGRP on calcium current was evaluated by evoking currents
from different holding potentials (Vh) at the same V, (+10 mV). CGRP-induced
increases in calcium currents were similar over the range of (Vh) from -60 to
-110 mV, suggesting that the peptide did not alter voltage-dependent steady-state
inactivation.
7. CGRP-induced enhancement of calcium current was antagonized by GDP-,f-S
(0-1 mM), a non-hydrolyzable analogue of GTP that prevents activation of G
proteins. The effect of CGRP was also abolished after neurones were treated with
100 ng/ml pertussis toxin (PTX) for 12-24 h.
8. In separate studies we examined the effect of CGRP on [3H]acetylcholine
release from isolated intact nodose ganglia. CGRP (0-01 and 1 /LM) produced a
concentration-dependent increase in acetylcholine release of 12+3 and 22+5%,
respectively, over basal release levels. The effect ofCGRP was absent in the presence
of calcium-free media or tetrodotoxin and reduced after treatment with PTX
(250 ng/ml for 3 h).
9. We conclude that CGRP enhanced primarily a transient high-threshold calcium
current component and stimulated acetylcholine release in nodose ganglion neurones
via a pertussis toxin-sensitive mechanism.
INTRODUCTION
Calcitonin gene-related peptide (CGRP) is a thirty-seven amino acid peptide
encoded in the calcitonin gene that is present in a variety of central and peripheral
neurones, including hypothalamic, primary afferent, and intrinsic neurones of the
gastrointestinal tract (Ishida-Yamamoto & Tohyama, 1989). CGRP increased
calcium current in rat dorsal root ganglion (DRG) neurones and enhanced excitatory
synaptic transmission in the spinal cord (Ryu, Gerber, Murase & Randic, 1988). In
addition, CGRP had an excitatory action on guinea-pig myenteric neurones and
coeliac ganglion neurones and stimulated acetylcholine release from --myenteric
ganglia (Palmer, Schemann, Tamura & Wood, 1986; Dun & Mo, 1989; Mullholland
& Jaffer, 1990). The mechanism by which CGRP altered calcium channel activity is
not known.
It is unknown, for example, whether enhancement of calcium currents by CGRP
was mediated by a guanine nucleotide binding (G) protein. Several inhibitory
neuropeptides including the K-receptor selective opioid peptide dynorphin A,
neuropeptide Y (NPY) and somatostatin decreased calcium currents (Gross &
Macdonald, 1987; Ewald, Sternweiss & Miller, 1988; Lewis, Weight & Luini, 1986)
via a pertussis toxin (PTX)-sensitive mechanism, suggesting that inhibitory (Gi/Go-
type) G protein(s) mediated this action (Lewis et al. 1986; Ewald et al. 1988; Gross,
Moises, Uhler & Macdonald, 1990). In addition, the a-subunit of Go 'reconstituted'
the effect of NPY to reduce calcium current in PTX-treated dorsal root ganglion
(DRG) neurones (Ewald et al. 1988). Previous studies have shown that pertussis
toxin blocked angiotensin II-induced stimulation of voltage-dependent calcium
currents in an adrenal cortical cell line and angiotensin II-induced calcium influx,
but not inositol trisphosphate production, in adrenal glomerulosa cells (Kojima,
Shibata & Ogata, 1986; Hescheler, Rosenthal, Hinsch, Wulfern, Trautwein &
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Schultz, 1988). Taken together, these studies suggest that PTX-sensitive G proteins
may mediate stimulatory as well as inhibitory effects of peptides on calcium currents.
Multiple low- and high-threshold voltage-dependent calcium current components
have been recorded from primary sensory neurone cell bodies. The transient low-
threshold (T-type), relatively transient high-threshold (N-type) and slowly in-
activating high-threshold (L-type) currents differed in their electrophysiological
properties and responses to application of pharmacological agents (Nowycky, Fox,
& Tsien, 1985; Wanke, Ferroni, Malgaroli, Ambrosini, Pozzan & Meldolesi, 1987;
Fox, Nowycky & Tsien, 1987 a, b; Gross & Macdonald, 1987). For example, the
snail toxin o)-conotoxin GVIA reduced neuronal N-type currents (McCleskey, Fox,
Feldman, Cruz, Olivera, Tsien & Yoshikami, 1987), whereas dihydropyridines
selectively inhibited the L-type current (Fox et al. 1987 a). Additional high-threshold
calcium currents have been recorded from a variety of neurones that exhibited
distinctive electrophysiological properties and sensitivity to the spider venom toxin
w-Aga-lllA but insensitivity to wo-conotoxin GVIA and dihydropyridines (Plum-
mer, Logothetis & Hess, 1989; Plummer & Hess, 1991; Regan, Sah & Bean, 1991;
Mintz, Venema, Adams & Bean, 1991). It is unknown if CGRP receptors couple to
one or more of these channel subtypes. Dynorphin A and NPY, for example,
primarily decreased transient high-threshold calcium currents in primary sensory
neurones (Gross & Macdonald, 1987; Wiley, Gross, Lu & Macdonald, 1990).
Differential coupling of neurotransmitter receptors to calcium channels is of
physiological interest in light of recent studies showing that different calcium
channel subtypes may be primarily responsible for modulating neurotransmitter
release (Perney, Hirning, Leeman & Miller, 1986; Hirning, Fox, McClesky, Olivera,
Thayer, Miller, Tsien, 1988). In a previous study we demonstrated that reduction of
a transient high-threshold calcium current by NPY correlated with a reduction in
evoked acetylcholine release (Wiley et al. 1990). Such correlations have not been
reported for stimulatory peptides such as CGRP.
The goals of this study were, therefore, to determine the effect ofCGRP on calcium
current components in rat vagal sensory (nodose ganglion) neurones, to determine
whether the coupling of CGRP receptors to calcium channels was G protein
dependent and to evaluate the effect ofCGRP on the release of the neurotransmitter
acetylcholine in the isolated nodose ganglion and assess whether G protein(s)
mediated this action.
METHODS
Preparation of acutely dissociated nodose ganglion neurones
Nodose ganglion neurones were prepared using methods described previously (Gross, Wiley,
Ryan-Jastrow & Macdonald, 1990). Briefly, rats were decapitated after ether anaesthesia; nodose
ganglia were removed and treated with 1 mg/ml type Ia collagenase (Sigma Chemical Company,
St Louis, MO, USA) in minimal essential medium (GIBCO Laboratories, Grand Island, NY)
buffered with 16-5 mM-NaHCO3 for 25 min at 37 'C. The tissue was then transferred to a tube
containing Dulbecco's minimum essential medium (GIBCO) and 5% fetal calf serum (GIBCO) to
inhibit the enzyme, triturated gently to disperse the cells and then centrifuged and resuspended in
minimum essential medium with Earle's salts supplemented with NaHCO3 (16-5 mM), glucose
(28-2 mM), nerve growth factor (10 ng/ml; Boehringer Mannheim, Indianapolis, IN, USA),
penicillin (50 U/ml), streptomycin (50 mg/ml), CaCl2 (3-6 mM) and 10% fetal calf serum (GIBCO).
The suspension (approximately 0-5 ml/ganglion) was plated on 35 mm polystyrene Petri dishes
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(Corning Glass Works, Corning, NY), without a substrate, 0 3 ml/dish and incubated at 37 TC in
a 93 % air-7 % CO2 atmosphere. An additional 1 ml of medium was added after 30 min, and the
cells were used for recordings within 1-24 h.
Whole-cell patch clamp recordings
Whole-cell voltage clamp recordings were obtained using the whole-cell variation of the patch
clamp technique. Cells were bathed in a solution containing (mM): 67 choline chloride,
100 tetraethylammonium, 5-6 glucose, 5-3 KCl, 5 0 CaCi2, 10 HEPES (pH 7 3-7-4) 310-330 mosM;
all reagents from Sigma. Glass recording patch pipettes (Fisherbrand microhaematocrit tubes,
Pittsburgh, PA, USA) with resistances of 1 0-2 0 MW were filled with a recording solution
containing (mM): 140 CsCl, 10 HEPES, 10 EGTA, 5 ATP-Mg2+ and either 0-1 GTP or GDP-fl-S,
guanosine, 5'-O-(2-thiodisphosphate) (all reagents from Sigma). The pH (7 3-7 4) was adjusted
with 1 M-CsOH after the addition of ATP. The osmolarity was 10-15% below that of the bath
solution, 280-300 mosM.
Recordings were made at room temperature using the Axopatch 1-C patch clamp amplifier
(Axon Instruments, Burlingame, CA, USA). Pipette and whole-cell capacitance and series
resistance were corrected by compensation circuitry on the patch amplifier. Typical initial input
resistances were 500 MW to 1GW. Series resistance was estimated by cancellation of the
capacitance-charging current transient after patch rupture; typical values for the series resistance
were 1-5-4 MQ. Generally, series resistance compensation of 80-90% was possible without
significant noise or oscillation. Voltage step commands were generated, and currents were digitized
(5 kHz), stored and analysed by a microcomputer (IBM AT or equivalent) using the program
pCLAMP (Axon Instruments). The current traces were filtered with a Bessel filter at 10 kHz
(-3 dB).
Analysis of current components
Leak current was estimated either as the inverse of the current evoked using hyperpolarizing
voltage commands of equal magnitude to the depolarizing commands used to evoked the inward
currents, or as the current evoked with depolarizing commands in the presence of cadmium chloride
(200 /M). Leak current was digitally subtracted from the relevant inward current to obtain the
calcium current. Leak currents were not affected by CGRP, GDP-/3-S or PTX.
At least three calcium current components were present in nodose ganglion neurones (Gross et
al. 1990), similar to the transient low-threshold (T-type), relatively high-threshold (N-type) and
slowly inactivating high-threshold (L-type) currents reported in dorsal root ganglion neurones
(Nowycky et al. 1985; Gross & Macdonald, 1987). The presence of additional high-threshold
calcium currents similar to the w-conotoxin- and dihydropyridine-insensitive currents reported in
other peripheral neurones has not been examined in nodose neurones (Plummer et al. 1989; Regan
et al. 1991; Mintz et al. 1991). The transient low-threshold current component was isolated by
evoking currents from holding potentials (V1h) = -80 or -90 mV at clamp potentials (Vc) = -50 to
-20 mV. At V1 positive to -20 mV more slowly inactivating high-threshold current components
were evoked. To distinguish between transient and slowly inactivating high-threshold current
components, we evoked currents at 1 min intervals after patch rupture, alternating between Vh of
-80 and -40 mV. The current evoked from Vh = -40 mV at V1 = + 10 to + 20 mV was used as an
estimate of the slowly inactivating high-threshold current component, and the current evoked from
Vh = -80 mV as an estimate of the transient high-threshold component. Results are presented in
terms of the evoked currents unless we refer to a specific current component. We use the
nomenclature T-type, N-type and L-type calcium current components to describe the transient
low-threshold, transient high-threshold and slowly inactivating high-threshold current com-
ponents, respectively with the understanding that the whole-cell technique does not allow
unequivocal identification of currents carried by channel subtypes. Statistical comparisons were
made by using Student's two-tailed t test.
Drug preparation and application
Rat CGRP (Pennisula Laboratories, Belmont, CA), was dissolved in external recording solution
supplemented with 0-1% bovine serum albumin (BSA, Sigma). Compounds were applied by
pressure ejection (1-7-6-9 kPa) for 2 s from micropipettes (tip diameters 10-15,m) that were
positioned 20-30 ,um from the cell body. Application of diluent had no effect on evoked calcium
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currents or holding currents. After application, micropipettes were removed from the bath.
Currents were evoked 5 s after completion of CGRP application.
For some experiments neurones were pre-incubated with PTX (Sigma). Four microlitres of
50 jug/ml in PTX in 0-1% BSA was added to neuronal cultures containing 2 ml of culture medium
resulting in a concentration of 100 ng/ml PTX. Control Petri dishes received 4 #u1 of 1% BSA.
Cultures were incubated for 12-24 h. Prior to recording, culture medium was exchanged for
external recording solution containing either 100 ng/ml PTX (treated cultures) or diluent (control
cultures). Comparisons were made between treated and untreated cultures of the same plating.
[3H]Acetylcholine (ACh) release studies
Postnatal rats (1-3 weeks old) were fasted for 12 h, anaesthetized by carbon dioxide inhalation
and decapitated. The nodose ganglia from nine animals were removed and cleaned of surrounding
connective tissue. The release of [3H]ACh from nodose ganglia was examined using a method similar
to that described previously (Wiley et al. 1990). Briefly, the isolated intact ganglia were incubated
for 1 h with [3H]choline (0-2 #M, specific activity 80 Ci/mmol) in 2 ml of oxygenated Krebs-Ringer
buffer. The baskets were serially transferred to scintillation vials containing fresh buffer every
10 min. At 40-50 and 80-90 min during the release period, baskets were placed into vials
containing 0-01 or 1-0 /M-CGRP. Some experiments were performed in calcium-free media
containing 2 mM-EGTA or in Krebs-Ringer buffer containing 1 /SM tetrodotoxin (TTX).
In experiments evaluating the effect of PTX, ganglia were pretreated of 3 h with PTX
(250 ng/ml) prior to the [3H]ACh release period. The concentration of PTX and duration of
pretreatment were derived from previous studies (Wiley et al. 1990). In each experiment ganglia
not exposed to PTX served as controls. In all experiments, total 3H was determined and used to
indicate transmitter release. Column chromatography was used to verify that the 3H released was
ACh as described previously (Wu, Kisslinger & Gaginella, 1982).
Fractional release was calculated by expressing the radioactivity in each vial as a percentage of
the total radioactivity in the tissue at the time of collection as described previously (Wiley &
Owyang, 1987). All results were expressed as means+ S.E.M. The number of experimental trials was
taken as the sample size.
RESULTS
CGRP increased the transient high-threshold calcium current component in nodose
neurones
We studied the effect of CGRP on the calcium current components of nodose
ganglion neurones. Calcium current components were similar to those described
previously (Gross et al. 1990; Wiley et al. 1990). Briefly, the low-threshold currents
generally remained stable during a typical 30 min recording period (not shown, see
Gross et al. 1990), whereas high-threshold currents decreased slowly to approximately
60% of their maximal values. Application ofCGRP had not effect on either the low-
threshold (Fig. 1A, traces 1 and 2) or slowly inactivating high-threshold currents
(Fig. 1B, traces 4 and 5). However, the peptide reversibly increased high-threshold
calcium currents containing the transient and slowly inactivating components in
thirty-two out of fifty-five neurones (Fig. 1B, traces 1, 2 and 3). The effect ofCGRP
was concentration dependent (1-1000 nM, ED50 = 50 nm). CGRP (1 J#M) produced a
mean increase of the peak current (Ip), evoked from Vh = -80 mV at VJ = + 10 to
+20mV, of 21+4% with a range 12+3 to 38+5% (mean+S.E.M.; P<005).
CGRP-mediated enhancement of calcium current was observed within 5 s of
application of the peptide. Calcium currents returned to control values within
1-3 min of CGRP application.
We examined whether CGRP affected the voltage dependence of calcium channel
activity, as has been suggested for neurotransmitters that decrease calcium current
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(Bean, 1989). A series of currents were evoked from Vh = -80 mV at VJ ranging from
-110 to + 80 mV, and the peak current values were plotted as a function of VI (Fig.
1 C). The maximum current typically occurred between 0 and + 10 mV (Fig. 1 C).
CGRP increased the maximal peak current and caused a modest negative shift of
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Fig. 1. CGRP selectively increased calcium currents in rat nodose ganglion neurones.
Currents are leak substracted and inward currents are downward. In this and subsequent
figures, representative voltage command protocols (mV) are shown above the calcium
current traces. The holding potential (V7h) and clamp potential (VJ) are depicted. Data
depicted in A-C were recorded from the same neurone using the whole-cell voltage clamp
technique. A, transient low-threshold calcium currents. Vh was -90 mV; the 100 ms step
command was to V, = -50 mV. B, high-threshold calcium currents. Slowly inactivating
high-threshold currents were evoked from Vh = -40 mV; the 100 ms command was to V,
= + 10 mV. High-threshold currents consisting of both transient and slowly inactivating
components were evoked from V7h = -80 mV at VJ = +10 mV. Superimposed traces
demonstrate currents before (traces 1 and 4) and 5 to 10 s after (traces 2 and 5) a 2 s
application of CGRP (1 /uM). Trace 3 shows recovery at 3 min after application of the
peptide. C, effect of CGRP on current-voltage relation. The current-voltage plot was
constructed from peak currents recorded before (control, *) and after (A) application of
CGRP (1 fM). Vh was -80 mV and currents were evoked using 100 ms hyperpolarizing
and depolarizing steps ranging from -110 mV to + 80 mV in 10 mV increments.
< 10 mV in the peak of the I-V relation in three out of six neurones. In the remaining
three neurones the peptide increased the maximal peak current without a detectable
shift in the peak of the I-V relation.
To determine whether CGRP increased the maximal calcium conductance we
studied the effect of peptide on the instantaneous I-V relation at a Vc positive to that
at which maximal calcium currents were evoked. During a large depolarizing
command from Vh = -80 mV to VI = + 30 mV, a series of 5 and 10 mV depolarizing
and hyperpolarizing commands were performed to generate an instantaneous I-V
relation. Representative current tracings, shown in Fig. 2Aa and b, reveal that
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CGRP increased the current required to attain a given voltage (Fig. 2B) consistent
with an increase in maximum calcium conductance (23+4%, n = 4; mean+S.E.M.).
We evaluated whether CGRP affected voltage-dependent steady-state inac-
tivation of calcium current by evoking calcium currents at the same VI from two
Aa Control
+30 > _ i
-80 - \ B nA
±1
10 -5 +5 +10
mV
Ab CGRP 10 Ms1
Fig. 2. CGRP increased the instantaneous current-voltage relation. Currents were evoked
from Vh = -80 mV at V, = +30 mV. During the large depolarizing command to V,
sequential 5 and 10 mV hyperpolarizing and depolarizing voltage steps were performed.
Currents before (control, A a) and after (A b) application of CGRP (1 /M) are depicted. B,
instantaneous current-voltage relation demonstrating the current recorded at the end of
each hyperpolarizing and depolarizing voltage step from V,. Control (e) and after
application of CGRP (A).
different Vh in the presence and absence of the peptide. If CGRP were enhancing
calcium current by reducing voltage-dependent steady-state inactivation, we would
anticipate observing a larger increase in calcium currents evoked from a more
positive Vh. Instead, we observed that the percentage increase in the peak calcium
current produced by CGRP was similar, if not somewhat greater, when currents were
evoked from, Vh=-ll1mV (28 + 4 %) compared to -60 mV (18+ 3 %) (n = 5,
P < 0 05; Fig. 3).
GDP-/-S and PTX prevented the CGRP-induced increase in calcium current
Experiments were designed to determine whether the pathway(s) by which CGRP
receptors were coupled to calcium channels involved G proteins. First we examined
the effect of substituting GDP-,/-S which prevents activation of G proteins (Casey &
Gilman, 1988) for GTP in the recording solution. CGRP was applied at 5 and 20 min
to control cells and to cells from the same preparation in which GDP-,f-S was
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Fig. 3. CGRP increased calcium current independently of a shift in the voltage
dependence of steady-state inactivation. The currents shown in A and B were recorded
from the same neurone before (trace 1) and after (trace 2) a 2 s application of CGRP
(1 uM). The currents were evoked from Vh=-60 mV (A) or Th=-1 10 mV (B) at VT
= + 10 mV for 100 ms.
Ab Control
5 min 20 min
+10 I
-70
1 and 3
1 and 3 2
2 1 nAL20 ms
Ba GDP-fl-S
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2
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, 20-
0)
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5min 20min
Fig. 4. CGRP-induced increase in calcium current was antagonized by GDP-fl-S. A and
B show the effect of CGRP at 5 and 15 min after patch rupture in a typical control cell
'dialyzed' with GTP (0-1 mM). C and D show the effect of substituting GDP-/-S (04 mM)
for GTP in a representative CGRP-responsive cell. The percentage increase in the peak
calcium currents (Ip) (mean S.E.M) are shown to the right of the current traces. Calcium
currents before (control, trace 1) and after CGRP (1 #M) application (trace 2) were evoked
from Vh=-80mV at IK=+lOmV forlOOms.
Aa Control
374
CGRP INCREASESL~ a AND ACh RELEASE3
substituted for GTP in the recording pipette solution (Fig. 4). In twelve of twenty-
one control cells CGRP increased the peak calcium current 20+4% at 5 min and
14+3% at 20 min in twelve out of twenty-two cells (P < 0 05) (Fig. 4Aa and b).
When GDP-,8-S was substituted for GTP in the recording pipette solution, CGRP
A Control
+10
-70
C
1 and 3 20 T
2 C
1 nA CDa
20 ms 10
B PTX
Control PTX
1 and 2
2 nA
20 ms
Fig. 5. Pertussis toxin (PTX) abolished CGRP-induced increase in calcium current. A.
CGRP increased the calcium current in seven of twelve untreated neurones. Calcium
currents are shown for a representative untreated cell before (control, trace 1), after
CGHRP (1 Bam) application (trace 2) and recovery (trace 3). B, after pretreatment with PTX
(100 ng/ml for 12-24 h) none of twelve neurones responded to application of CGRP. Cells
tested were from the same plating. Calcium currents before (trace 1) and after (trace 2)
CGRP application were evoked from Vh = -70 mV at V, = + 10 mNr for 100 ins. C.
histogram shows response to application ofCGRP for untreated (control) cells and treated
(PTX) cells. Results are presented as a percentage increase in the peak (I,) of the calcium
current after application of CGRP compared to control currents.
increased the peak calcium current 12 + 3 % at 5 min and 3 + 2% at 20 min of six of
twelve cells (Fig. 4Ba and b). The negligible increase in the peak calcium current
produced by CGRP at 20 min in cells 'dialysed' with GDP-fl-S was not significantly
greater than control currents.
We studied the effect of CGRP in the presence of pertussis toxin (PTX) by
comparing the effect of CGRP on cells exposed to PTX for 12-24 h after plating to
time-matched control (vehicle-treated) cells from the same preparation. CGRP
significantly increased the peak calcium current evoked at V, = + 10 mV from Vh =
-70 mV in seven out of twelve control cells (Fig. 5A) but had no effect on twelve
cells pretreated with PTX (Fig. 5B). The results are summarized in Fig. 5C.
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CGRP stimulated acetylcholine release in the nodose ganglia via a PTX-sensitive
mechanism
We examined the effect of CGRP on acetylcholine (ACh) release in excised intact
nodose ganglia to correlate our observations on calcium currents with the release of
T
20-
~0
10 0
Fig. 6. CGRP-stimulated acetylcholine (ACh) release in nodose ganglia was reduced by
pertussis toxin (PTX). CGRP (0 01 and 1 0 1tm)-induced release of[1H]ACh from excised
intact nodose ganglia was tested after pretreatment with PTX (250 ng/ml for 3 h) in the
presence of calcium-free media containing EGTA (2 mM) or after treatment with
tetrodotoxin (1 ItM). Number of results in each experiment is given within columns.
a classical neurotransmitter known to be present in this preparation (Cooper, 1984;
Ternaux, Falemopin, Palouzier, Chamoin & Portalier, 1989). Specifically, we
evaluated: (i) whether CGRP induced calcium-dependent release of ACh and (ii)
whether CGRP-evoked release of ACh was PTX sensitive. CGRP (0-01 and 1-0 /IM)
produced a concentration-dependent increase of 12 + 3 and 22 + 5 %, respectively, in
the release of acetylcholine over basal levels (mean+ S.E.M., P < 0-05) (Fig. 6).
CGRP-evoked release of acetylcholine was blocked in the presence of calcium-free
medium containing EGTA (2 mM; n = 4) and by tetrodotoxin (1 4aM; n = 4).
Pretreatment with PTX significantly reduced the stimulatory effect of CGRP on
acetylcholine release by 73% (n = 8, P < 0-05).
DISCUSSION
This study demonstrated that CGRP selectively increased a voltage-activated
calcium current and acetylcholine release in rat nodose neurones via a pertussis
toxin-sensitive mechanism. Ryu et al. (1988) reported that CGRP enhanced calcium
current and synaptic transmission in rat dorsal root ganglion neurones. Our results
confirm and extend their observations by showing that CGRP preferentially
enhanced a transient high-threshold calcium current component and acetylcholine
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release in vagal sensory neurones via a pertussis toxin-sensitive pathway. Our data
suggest that CGRP increased the N-type current component. However, additional
single-channel and pharmacological studies will be needed to determine un-
equivocally ifCGRP acts on one or more subtypes of transient high-threshold calcium
currents (Plummer et al. 1989; Plummer & Hess, 1991; Regan et al. 1991; Mintz et
al. 1991).
Previous studies have shown that pertussis toxin blocked angiotensin 11-induced
stimulation of voltage dependent calcium currents in an adrenal cortical cell line and
angiotensin 11-induced calcium influx, but not inositol trisphosphate production, in
adrenal glomerulosa cells (Kojima et al. 1986; Hescheler et al. 1988). Taken together
these studies suggest that PTX-sensitive G protein(s) can mediate the effects not
only of transmitters that reduce calcium currents but also the effects of stimulatory
transmitters.
Potential mechanisms that could explain the enhancement of calcium currents
produced by CGRP include: (i) increasing the number of open channels at a given
clamp potential, (ii) shifting the voltage dependency of calcium channel activation
in the negative direction which would have the effect of opening channels at more
negative clamp potentials but the maximum number of open channels would remain
the same, (iii) increasing the single-channel amplitude and/or (iv) increasing the
channel open time. Our data suggest that the enhancement in calcium currents by
CGRP in rat nodose ganglion neurones was associated with an increase in maximal
calcium conductance, as shown by the instantaneous current-voltage relation.
However, in three neurones CGRP produced a modest increase (- 12 %) in calcium
current and a negative shift (- 5 mV) in the peak of the current-voltage relation,
but without a detectable increase in conductance. The data from these two cells
suggest, by contrast, that the increase in calcium current may be due to a
transmitter-induced change in the voltage dependence of channel activation. It has
been proposed, for example, that neurotransmitters that reduce calcium current act
to alter the voltage dependence of channel activation (Bean, 1989). We do not feel,
however, that such a modest shift in the I-V relation should be taken as unequivocal
evidence of a transmitter-induced change in the voltage-dependent properties of
calcium channels. For the typical 20% increase in peak current produced by CGRP
(1 aM), a negative shift of 10-20 mV in the peak ofthe I-V relation would be expected
if the peptide was acting solely by altering the voltage dependence of channel
activation. We did not observe shifts in the peak of the I-V relation of this
magnitude. In separate studies, we examined whether CGRP increased calcium
current by altering the voltage dependence of steady-state inactivation. Our studies
indicated that the percentage increase in the peak calcium current produced by
CGRP was similar, if not somewhat greater, when currents were evoked at
Vc = + 10 mV from Vh = -110 mV compared to Vh = -60 mV, suggesting that the
peptide's effect occurred independently of a shift in the voltage dependence of
steady-state inactivation over this range. Although our data do not allow a definite
statement regarding the mechanisms) by which CGRP increased calcium currents,
we favour the view that more calcium channels are opened in the presence of the
peptide, since the results do not strongly support the hypothesis that the peptide
altered voltage-dependent properties.
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The signal transduction pathway(s) underlying the G protein-dependent CGRP-
mediated increase in calcium current remains to be fully elucidated, however. It is
unclear, for example, whether the specific pathway involved direct coupling of the
G protein to the calcium channel or indirect coupling via second messenger
pathway(s) such as a cyclic AMP-dependent pathway. Since CGRP increased
adenylate cyclase activity in other preparations, it is possible that the peptide acted
via Gs to directly or indirectly activate calcium channels. Direct coupling of G, to
activation of calcium channels has been reported in cardiac myocytes (Yatani,
Codina, Imoto, Reeves, Birnbaumer & Brown, 1987). Indirect activation of calcium
current in cardiac myocytes and hippocampal neurones via cyclic AMP-dependent
phosphorylation occurred with application of /J-adrenoceptor agonists (Reuter,
1983; Kameyama, Hofmann & Trautwin, 1985; Kameyama, Hescheler, Hofmann &
Trautwein, 1986; Gray & Johnston, 1987). In addition, the cyclic AMP-dependent
protein kinase catalytic subunit selectively increased calcium current components in
rat nodose neurones (Gross, Uhler & Macdonald, 1990). While these observations
suggest that enhancement of calcium current can occur either via Gs or through
cyclic AMP-dependent phosphorylation of calcium channels (or associated proteins),
they do not readily explain our observation that the effect of CGRP was antagonized
by PTX, which blocks the actions of G1/Go-type G proteins. These proteins are more
commonly thought of as mediating the inhibition of adenylate cyclase or the
reduction of calcium currents by inhibitory neurotransmitters. It is possible, for
example, that Gi/Go-type G proteins subserve tonic inhibition of the adenylate
cyclase-cyclic AMP system and that PTX, by inactivating Gj/G0 produced a full
activation of this pathway. If the effect of CGRP on ICa was the result of increased
intracellular levels of cyclic AMP, this would result in a PTX-sensitive 'blockade' of
its stimulatory action, because the pathway would be maximally activated in the
presence of PTX. This hypothesis is supported by the observation that cardiac
myocytes preincubated with pertussis toxin exhibited a twofold increase in the L
calcium current component, suggesting that a pertussis toxin substrate significantly
inhibited ICa in the basal state (Keung & Karliner, 1990). Thus, the present results
support the idea that the coupling of CGRP receptors to calcium channels is G
protein dependent, but further studies will be necessary to determine the exact
nature of the biochemical pathway(s) involved.
We also examined the effect of CGRP on the release of the neurotransmitter
acetylcholine in excised intact nodose ganglia to determine if CGRP-induced release
of this neurotransmitter was calcium-dependent and pertussis toxin-sensitive. The
nodose ganglion is a useful preparation to study the regulation of acetylcholine
release because the neurotransmitter is present and dispersed nodose neurones are
known to form nicotinic-type synapses in culture (Cooper, 1984; Ternaux et al. 1989).
CGRP induced calcium-dependent release of acetylcholine that was significantly
reduced after treatment with PTX and was blocked by tetrodotoxin. Thus, both
CGRP-induced enhancement of calcium current and stimulation of acetylcholine
release were PTX sensitive. The cellular mechanisms) underlying CGRP-induced
release of acetylcholine in nodose ganglion neurones remain to be clarified. Our
neurotransmitter release studies were performed in Krebs-Ringer buffer; therefore,
we cannot rule out that CGRP may also act on other ion channels, in addition to
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calcium channels, to stimulate acetylcholine release. For example, CGRP evoked
three types of excitatory responses in guinea-pig coeliac ganglion cells: a fast, a slow
and a biphasic depolarization supporting involvement of different ion conductances
(Dun & Mo, 1989). In myenteric neurones the primary mechanism underlying CGRP-
induced slow depolarization appeared to involve inactivation of a calcium-activated
potassium conductance (Palmer, Schemann, Tamura & Wood, 1986). CGRP-
mediated release of acetylcholine may also involve activation of second messenger
pathways. For example, studies involving myenteric neurones indicated that CGRP
stimulated acetyleholine release via a cyclic AMP-dependent pathway (Mullholland
& Jaffer, 1990). Therefore, it is possible that CGRP-induced release of acetyleholine
in nodose neurones may utilize a cyclic AMP-dependent pathway (see above).
Alternatively, CGRP receptors could be coupled via a PTX-sensitive form of the G
protein GP to activation of phospholipase C, mobilization of intracellular calcium and
the subsequent release of acetyleholine. Our data suggest, however, that activation
of calcium channels is responsible, at least in part, for the CGRP-induced increase in
acetylcholine release.
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